Ad26.COV2.S

Johnson & Johnson COVID-19 vaccine (Ad26.COV2.S) · Janssen Vaccines & Prevention B.V.

Drug timelines are a Plus or Pro feature.

9 regulatory and trial events tracked for Ad26.COV2.S, covering 2020-12-01 to 2024-11-13. Get the full timeline:

Most recent: Clinical Trial Update: A Study of Ad26.COV2.S in Healthy Pregnant Participants (COVID-19) [Phase 2]